Bionano Genomics, Inc. (BNGO) › Shareholders' EquityBionano Genomics, Inc. (BNGO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$27.26M2017: -$50.23M2018: $10.14M2019: $3.61M2020: $35.08M2021: $337.12M2022: $249.40M2023: $96.16M2024: $35.38M2025: $44.42M$44.42M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$44.42M+25.6%2024$35.38M-63.2%2023$96.16M-61.4%2022$249.40M-26.0%2021$337.12M+860.9%2020$35.08M+871.0%2019$3.61M-64.4%2018$10.14M+120.2%2017-$50.23M-84.3%2016-$27.26M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share